Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma.
暂无分享，去创建一个
A. Nademanee | D. Gandara | P. Frankel | S. Forman | A. Rotter | V. Pullarkat | J. Zain | M. Kirschbaum | I. Espinoza‐Delgado | E. Newman | L. Popplewell | M. Delioukina | B. Pulone | Deron Matsuoka